gene@lifeview.com
Preimplantation Genetic Testing (PGT), helps identify chromosomal abnormalities and genetic disorders in embryos before implantation, allowing you to select the healthiest embryo for transfer and increase the chances of a successful pregnancy.
About us
Unlike any other service in the world, LifeView patients also have access to Embryo Health Scores, which have been proven to reduce the risk of common diseases like diabetes, cancer, and heart disease in your embryo.
LifeView™ PGT provides the most advanced genetic screening for the IVF embryo available. Studies comparing LifeView to conventional testing methods proved higher pregnancy rates and lower miscarriage rates.
PGT-A screens embryos for aneuploidy so that you and your care team can select an embryo with the correct number of chromosomes (euploid) for transfer, increasing your chances of success and a healthy child.
PGT-A+ is done in conjunction with PGT-A and indicates if the chromosome abnormality originated from the egg (maternal) or sperm (paternal). PGT-A+ requires saliva samples from the patient, partner, and/or gamete donor in addition to embryo samples.
Monogenic disorders are inherited conditions caused by genetic variants in a single gene. PGT-M is designed for individuals who have a higher chance of passing on these types of conditions to their children.
The LifeView Embryo Health Score test evaluates genetic variants to assess the risk of polygenic conditions like diabetes, cancer, schizophrenia, and heart disease in your future child. It also helps you and your clinician compare disease risks among embryos to decide which one to prioritize for transfer.
Individuals who are carriers of balanced chromosome rearrangements have a higher chance of creating embryos with extra or missing genetic material. This can lead to fertility problems, pregnancy loss and health issues in an ongoing pregnancy. PGT-SR is designed to select embryos without such chromosome rearrangements for transfer.
Biological parents are screened for a gene associated with increased miscarriage risk. Testing for the M2 haplotype is simple and only requires a saliva sample from the biological parents. If the M2 haplotype is present in any of the biological parents it is possible to screen the embryos for the genetic variant.
Empowering Information
PGT-A+ is done in conjunction with PGT-A and indicates if the chromosome abnormality originated from the egg (maternal) or the sperm (paternal).
Used and loved by people at leading companies
If you are unable to find a clinic close to you, we are happy to work with you to onboard your IVF facility. Contact gene@lifeview.com for more information.
Number | First Name | Last Name | Email Address |
---|---|---|---|
1 | Anne | Evans | anne.evans@mail.com |
2 | Bill | Fernandez | bill.fernandez@mail.com |
3 | Candice | Gates | candice.gates@mail.com |
4 | Dave | Hill | dave.hill@mail.com |